Effect on Glycemic Control of Two Doses of Liraglutide versus Glimepiride in Type 2 Diabetes

Grants and Contracts Details

StatusFinished
Effective start/end date8/1/067/31/08

Funding

  • Novo Nordisk Pharmaceuticals Inc: $17,364.00